pfizer inc (PFZ:London)
Transactions by PFIZER INC (PFZ) in the last 6 months
Alvogen, Inc. agreed to acquire Four Pharmaceutical Products from Pfizer Inc. (NYSE:PFE) on August 24, 2015. The assets being acquired include an attractive portfolio of three injectable products and one inhaled solution product. Two are on-market products, Clindamycin injection and Acetylcysteine inhalation solution. Acetylcysteine will continue to be marketed by Fresenius with Alvogen receiving profit sharing payments. In addition, Alvogen will acquire two pending ...
XRpro Sciences, Inc. entered into an asset purchase agreement to acquire Icagen, Inc from Pfizer Inc. (NYSE:PFE) for $11 million on June 26, 2015. Under the terms of the agreement, XRpro agreed to pay: (i) an upfront cash purchase price of $0.5 million, of which $0.125 million was paid at closing date, and $0.375 million is to be paid in three equal installments of $0.125 million, on September 1, 2015, December 1, 2015 and March 1, 2016; (ii) a cash payment of $0.5 million ...
Pfizer Inc. (NYSE:PFE) acquired 17.5% stake in AM-Pharma B.V. on May 11, 2015. Pfizer Inc. acquired minority stake and an exclusive option to acquire the remaining equity in AM-Pharma. Pfizer made an upfront payment of $87.5 million for the minority equity interest and exclusive option, with additional potential payments of up to $512.5 million upon option exercise and potential launch of any product that may result from this agreement. Clifford Chance LLP and Jonathan ...
|Bayer AG||€117.42 EUR||-4.46|
|Gilead Sciences Inc||$102.06 USD||+0.15|
|Johnson & Johnson||$91.31 USD||-1.33|
|Nestle SA||SFr.70.55 CHF||-0.55|
|Procter & Gamble Co/The||$68.76 USD||-1.17|
|View Industry Companies|